Roberta S. Batorsky - Concepedia

Author

Roberta S. Batorsky

Bristol-Myers Squibb (United States)

Also Known As

Roberta Batorsky, Roberta S. Batorsky

Publications

969

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)

About

Roberta S. Batorsky is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	950
2	Natural Sciences	4	4	387
3	Biochemistry	4	4	387
4	Health Sciences	1	1	251
5	Cell Biology	1	1	262

Roberta S. Batorsky

Publications

950

Citations

H-Index

Page 1

	Year	Citations
Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic <i>BRAF</i> by the Kinase Inhibitor SB-590885 Alastair J. King, Denis R. Patrick, Roberta S. Batorsky, Cancer Research PathologyOncogenic Braf AllelesTumor BiologyOncologyTumor Phenotype	2006	262
<i>N</i>-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent Raj N. Misra, Hai‐Yun Xiao, Kyoung S. Kim, Journal of Medicinal Chemistry Chemoprevention StrategyImmunologyPharmacotherapyCdk2/cyce IcPharmaceutical Chemistry	2004	251
Discovery of Aminothiazole Inhibitors of Cyclin-Dependent Kinase 2: Synthesis, X-ray Crystallographic Analysis, and Biological Activities Kyoung Soon Kim, S. David Kimball, Raj N. Misra, Journal of Medicinal Chemistry Combinatorial ChemistryDrug TargetCdk2 ProteinCompound 14Heterocycle Chemistry	2002	156
Discovery of (<i>R</i>)-7-Cyano-2,3,4,5-tetrahydro-1-(1<i>H</i>-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1<i>H</i>-1,4-benzodiazepine (BMS-214662), a Farnesyltransferase Inhibitor with Potent Preclinical Antitumor Activity John T. Hunt, Charles Z. Ding, Roberta S. Batorsky, Journal of Medicinal Chemistry Medicinal Chemistry-1,4-Benzodiazepine FarnesyltransferaseBiochemistryChemoprevention StrategyMedicine	2000	134
Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases Raj N. Misra, Hai‐Yun Xiao, David Williams, Bioorganic & Medicinal Chemistry Letters Biological ActivityCyclin-dependent KinasesBiochemistryPotent Pan InhibitorsMedicine	2004	56
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors Kyoung Soon Kim, Songfeng Lu, Lyndon A. M. Cornelius, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicinePharmacotherapyDrug DevelopmentEg5 Inhibitors	2006	50
Discovery and Structure−Activity Relationships of Imidazole-Containing Tetrahydrobenzodiazepine Inhibitors of Farnesyltransferase Charles Z. Ding, Roberta S. Batorsky, Rajeev S. Bhide, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryIp Antitumor ActivityBiochemistryMedicine	1999	41

Page 1